Search
for
Sort by
Research 31–60 of 1000+
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- Notes from the Editor Emeritus: Medical therapy for hair loss: what we know and what we need to find out
- Sex differences in arterial hypertension
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Flavonoids and saponins: What have we got or missed?
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Nocebo effect in Dermatology
- A review on Hair Loss & Damage
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: Perspective for a biological origin of sexual dysfunction in PCOS
- Current Literature Review
- Post-finasteride syndrome
- An (Ir)reversible Affection of the Sexual Sphere: A Case Report
- The connection of 5-alpha reductase inhibitors to the development of depression
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- The pathophysiology of delayed ejaculation
- Nonsurgical Therapy for Hair Loss